VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL

Regulatory Information

HSA regulatory responsibility and product classification details

RegistrantASTELLAS PHARMA SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Class

Prescription Only

HSA Singapore Classification

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route of Administration

INTRAVENOUS

ATC Code

L01FX31

Pharmaceutical Manufacturer

ASTELLAS PHARMA SINGAPORE PTE. LTD.

Manufacturers

Baxter Oncology GmbH

Ingredient Name

Zolbetuximab

Strength

100mg/vial

Drug MonographZolbetuximab

Vyloy PI.pdf

Approved: March 6, 2025